Restrictive and diversifying elements of the anti-myelin/oligodendrocyte glycoprotein antibody response in primate experimental allergic encephalomyelitis

被引:6
|
作者
von Büdingen, HC
Menge, T
Hauser, SL
Genain, CP
机构
[1] Univ Calif San Francisco, Sch Med, Dept Neurol, San Francisco, CA 94143 USA
[2] Univ Zurich Hosp, Dept Neurol, CH-8091 Zurich, Switzerland
[3] Univ Hosp Dusseldorf, Dept Neurol, D-40225 Dusseldorf, Germany
关键词
experimental allergic encephalomyelitis; multiple sclerosis; myelin-oligodendrocyte glycoprotein; autoantibodies; immunoglobulin genes;
D O I
10.1007/s00251-006-0100-y
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Autoantibody responses against conformational epitopes of myelin/oligodendrocyte glycoprotein (MOG) possess myelin destructive potential, as demonstrated in the marmoset model of human multiple sclerosis (MS) and in some rodent models of experimental allergic encephalomyelitis. We have previously characterized monoclonal Fab fragments specific for conformational epitopes of MOG that were derived from a combinatorial antibody library generated from a MOG-immune marmoset. In this paper, we address the molecular heterogeneity of humoral responses against MOG in this outbred model of MS by studying additional antibody clones derived from a genetically unrelated animal. We find that all MOG-specific IgG kappa Fab fragments, unrelated to genetic make-up, utilize a restricted set of variable region genes, IGHV1 and IGHV3 for the H chain and IGKV1, IGKV3, and IGKV5 for the L chain. Despite these restricting factors, diversity within these antibody repertoires can be observed, predominantly within the H-chain CDR3 regions. Our findings suggest that only a limited set of Ig genes is necessary to launch a diverse, destructive humoral immune response against a single CNS antigen in primates. These results are the first to contribute to a better understanding of how myelin-directed and potentially destructive autoantibody responses may develop in human MS.
引用
收藏
页码:122 / 128
页数:7
相关论文
共 50 条
  • [41] Clinical Features and Prognostic Factors in Anti-Myelin Oligodendrocyte Glycoprotein Antibody Positive Optic Neuritis
    Takai, Yasuyuki
    Yamagami, Akiko
    Iwasa, Mayumi
    Inoue, Kenji
    Wakakura, Masato
    Takahashi, Toshiyuki
    Tanaka, Keiko
    NEURO-OPHTHALMOLOGY, 2024, 48 (02) : 134 - 141
  • [42] Evolution in anti-myelin oligodendrocyte glycoprotein antibody detection and its clinical significance: a narrative review
    Zhong, Xiaonan
    Wang, Yina
    Luo, Wenjing
    Ma, Xiaoyu
    Sun, Xiaobo
    Jiang, Boxiong
    Qiu, Wei
    ANNALS OF PALLIATIVE MEDICINE, 2021,
  • [43] Aseptic Meningitis as an Initial Manifestation of Anti-myelin Oligodendrocyte Glycoprotein Antibody-associated Disease
    Suzuki, Takehiro
    Maekawa, Kota
    Matsuo, Ko
    Yamasaki, Masayoshi
    Shibata, Masunari
    Takahashi, Toshiyuki
    Naito, Yutaka
    INTERNAL MEDICINE, 2019, 58 (22) : 3319 - 3321
  • [44] Anti-myelin Oligodendrocyte Glycoprotein Antibody-positive Optic Neuritis in a Girl With Ulcerative Colitis
    Konishi, Ken-Ichiro
    Mizuochi, Tatsuki
    Takaki, Yugo
    Ishihara, Jun
    Suda, Masao
    Takahashi, Toshiyuki
    Yamashita, Yushiro
    JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION, 2019, 69 (04): : E117 - E117
  • [45] Anti-myelin antibodies modulate experimental allergic encephalomyelitis in Biozzi ABH mice.
    Morris, MM
    Piddlesden, S
    Groome, N
    Amor, S
    BIOCHEMICAL SOCIETY TRANSACTIONS, 1997, 25 (02) : S168 - S168
  • [46] The FcRγ chain is not essential for induction of experimental allergic encephalomyelitis (EAE) or anti-myelin antibody-mediated exacerbation of EAE
    Breij, ECW
    Heijnen, P
    Vloet, R
    Saito, T
    van de Winkel, JGJ
    Dijkstra, CD
    Amor, S
    Verbeek, S
    JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 2005, 64 (04): : 304 - 311
  • [47] Anti-myelin oligodendrocyte glycoprotein (anti MOG) antibodies in Neuromyelitis optica patients
    Zarkesh-Esfahani, Sayyed Hamid
    Mirmosayyeb, Onnid
    Manouchehri, Navid
    Shaygannejad, Vahid
    JOURNAL OF IMMUNOLOGY, 2017, 198 (01):
  • [48] Seasonal variation of onset in patients with anti-aquaporin-4 antibodies and anti-myelin oligodendrocyte glycoprotein antibody
    Akaishi, Tetsuya
    Fujimori, Juichi
    Takahashi, Toshiyuki
    Misu, Tatsuro
    Takai, Yoshiki
    Nishiyama, Shuhei
    Kaneko, Kimihiko
    Ogawa, Ryo
    Abe, Michiaki
    Ishii, Tadashi
    Aoki, Masashi
    Fujihara, Kazuo
    Nakashima, Ichiro
    JOURNAL OF NEUROIMMUNOLOGY, 2020, 349
  • [49] Delayed Diagnosis of Anti-Myelin Oligodendrocyte Glycoprotein One Decade After Presumed Recurrent Acute Disseminated Encephalomyelitis
    Zehden, Jason
    Harish Bindiganavile, Shruthi
    Bhat, Nita
    Lee, Andrew G.
    Avery, Robert
    Golnik, Karl C.
    JOURNAL OF NEURO-OPHTHALMOLOGY, 2022, 42 (02) : E469 - E472
  • [50] Rituximab was effective for acute disseminated encephalomyelitis followed by recurrent optic neuritis with anti-myelin oligodendrocyte glycoprotein antibodies
    Nagashima, Masako
    Osaka, Hitoshi
    Ikeda, Takahiro
    Matsumoto, Ayumi
    Miyauchi, Akihiko
    Kaneko, Kimihiko
    Nakashima, Ichiro
    Nakano, Yuko
    Wakabayashi, Kei
    Monden, Yukifumi
    Yamagata, Takanori
    BRAIN & DEVELOPMENT, 2018, 40 (07): : 607 - 611